AUTOMA+ 2025 will gather pharmaceutical and biotechnology professionals from around the world Nov. 24–25 in Vösendorf, Austria, to exchange insights on automation and digitalization in pharmaceutical operations. While the congress emphasizes European participation, attendees from other regions will broaden the exchange of ideas. European participants include several Spanish pharmaceutical organizations. RidNova Pharmaceuticals, a contract development…
This week in semiconductor news: TSMC’s $100B investment, Broadcom’s strong earnings, Trump threatening to repeal CHIPS Act, and more
Major investments, policy debates, and sustainability efforts are reshaping the semiconductor industry. TSMC’s $100 billion U.S. expansion carries geopolitical significance, while Broadcom’s strong earnings highlight AI’s growing role. Siemens is investing $285 million in U.S. manufacturing, adding to its long-term growth. Meanwhile, the CHIPS Act faces scrutiny, with Trump calling for its repeal. The Semiconductor…
In 2024, the US and Europe led in pharma value creation while GLP-1s disrupted the landscape
GLP-1 juggernauts Eli Lilly and Novo Nordisk, whose combined $1.18 trillion market cap now exceeds Johnson & Johnson, AbbVie, and Merck combined, have staked their claim as stock market darlings. This momentum is particularly evident in Novo Nordisk’s remarkable trajectory, reaching a $604 billion market capitalization by March 2024 and securing its position as the…